Postmarketing evidence of disease-modifying drugs in multiple sclerosis
- 9 August 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neurological Sciences
- Vol. 29 (2), 225-226
- https://doi.org/10.1007/s10072-008-0944-z
Abstract
There is growing interest in the use of observational data to estimate treatment effects in chronic diseases such as multiple sclerosis (MS). The main results derived from postmarketing evaluations, in the last 2 years, of short-and long-term disease modifying drugs (DMDs) effectiveness will be reported in this Review. Moreover, some of the methodological improvements that may be useful to enhance the quality of observational studies will also be discussed.Keywords
This publication has 11 references indexed in Scilit:
- How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?Neurology, 2007
- Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?Neurology, 2007
- New natural history of interferon‐β–treated relapsing multiple sclerosisAnnals of Neurology, 2007
- Estimating Treatment Effects Using Observational DataJama-Journal Of The American Medical Association, 2007
- MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosisMultiple Sclerosis Journal, 2006
- The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trialsStatistics in Medicine, 2006
- The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNbeta exposure in multiple sclerosis.2006
- The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosisMultiple Sclerosis Journal, 2006
- Methods in health services research: Interpreting the evidence: choosing between randomised and non-randomised studiesBMJ, 1999
- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStatistics in Medicine, 1998